|
|
Please Click here or the link above
for the location and directions to the Meeting Site.
|
|
What Investors Really Want To See In Your Business Plan
|
|
| |
Back to Calendar |
Directions to the meeting |
Cost
and Times |
|
(This is an important
election night so vote early or get an absentee ballot, and
don�t miss this meeting!) |
 |
Meeting Overview:
The business plan is your primary vehicle for conveying
an organized thought process to investors about your
business, team, and pathway to success. Successful
entrepreneurs and their investors recognize that to raise
capital and grow their businesses, they need well-conceived
and implemented business plans. Our panel consists of three
successful investors (venture capitalists & angels) who have
also been successful CEOs. They will provide advice on how
to put a business plan together, tell you what works and
doesn�t work in today�s investment climate, network with
you, and answer your questions.
|
|
|
|
|
|
Meeting Site and Cost:
5:15 PM Pre-meeting Dinner
Bertucci's Restaurant
475 Winter St.,(exit 27B off Route 128), Waltham, MA ("pay-as-you-go")
7:00 PM Meeting Presentation
Conference Center
Bay Colony Office Park
1100 Winter Street, Waltham, MA
There is a $20.00 fee, non ENET members.
No reservations are necessary for either the meeting or dinner
Click here for directions and a map to the dinner and meeting
|
|
Panel: |
Ben Bronstein
is a Managing Director of Zero Stage Capital (www.ZeroStage.com),
a venture capital firm investing in early-stage,
technology-based companies. Prior to joining Zero
Stage he co-founded and ran several biotechnology
companies, including Peptimmune, a VC-backed company
that was acquired by Genzyme in 1999. From 1989-1993
he served as VP of Medical Affairs and Medical
Director of BioSurface Technology, which went public
and was later acquired by Genzyme. He received AB
(Phi Beta Kappa), MD, and MBA degrees - all from
Boston University � and served on the staff of the
Massachusetts General Hospital and the faculty of
Harvard Medical School.
|
|
Top of page |
Arthur Fox
co-founded and is President of Royalty
Capital Fund, the first successful venture capital
fund to employ a unique, royalty-based investment
methodology that he conceived. For over 30 years he
has been involved in the formation, financing,
operation, and divestment of business firms. He was
the co-founder and Executive VP of Octek, Inc.,
which was acquired by a Fortune 500 company in 1984.
He co-founded Lexidata Corporation, which went
public in 1981. He also co-founded Medicel and
served there as VP and Director. He holds an MSEE
degree from MIT and a BSEE degree from the
University of Maryland.
|
|
Top of page |
James Geshwiler
is Managing Director of Common
Angels (www.CommonAngels.com), the largest and most
active Angel group in New England. He has
participated in funding 18 companies through over 55
rounds of funding totaling over $100 million. Within
Common Angels he manages the deal flow, due
diligence, and the investment process. He is also
co-founder and Chairman of the Angel Capital
Association, which ties together 45 Angel groups
across the country. He received an MBA degree from
MIT Sloan School of Management and graduated Phi
Beta Kappa from the University of Texas.
|
|
Top of page |
| Moderators: |
Alan Silver has been the part-time Chief Financial
Officer (www.PartimeCFO.com) for over 40 technology
start-ups over the last 9+ years. At Andover.net he
was the part-time CFO from when the company had
fewer than 10 employees until just 5 months before
the company went public. He has an MSM degree from
the MIT Sloan School of Management, is Treasurer of
Boston Entrepreneurs� Network, and is an occasional
panelist at MIT Enterprise Forum Start-Up Clinics.
|
| |
|
|
